Yuhuai Hu

机构：Dahua Technology (China)

发表论文 16 篇 · 总被引 254 次 · h-index 6

代表论文

• Clinical practice guidelines for the management of neuropathic pain: a systematic review (2015 · BMC Anesthesiology · 被引 118)
• Regulation of p53 stability as a therapeutic strategy for cancer (2021 · Biochemical Pharmacology · 被引 50)
• Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis (2023 · Nature Communications · 被引 39)
• Enhanced proliferation inhibition and apoptosis in glioma cells elicited by combination of irinotecan and imatinib (2020 · European Journal of Pharmacology · 被引 14)
• Keratinocytes apoptosis contributes to crizotinib induced-erythroderma (2019 · Toxicology Letters · 被引 9)
• The impact of solute carrier proteins on disrupting substance regulation in metabolic disorders: insights and clinical applications (2025 · Frontiers in Pharmacology · 被引 8)